AILEEN ALVIAR: Open Payments
NPI 1205562246 · GILROY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$100 in 5 payments from 5 companies in 2025. Trend: 2023 $114 · 2024 $410 · 2025 $100
Food & beverage: $100
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| AngioDynamics, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: VERQUVO, LEQVIO, ALPHAVAC, VYNDAQEL, JARDIANCE.
Industry payments across CA — which companies pay providers there.
